drugset / Trial / NCT00353184

Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years

NCT00353184

RandomizedParallel-groupDouble-blindTreatment

Summary

Oral montelukast is helpful in chronic asthma. The purpose of this pediatric study was to investigate whether the addition of oral montelukast to standard therapy for acute asthma exacerbations results in further improvement in breathing function over three hours.

Timeline

Start
2001-09
Primary completion
2004-10
Completion
2005-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 5 mg Oral

Indications